Partnering
Investigator Sponsored Research
Research Collaboration Opportunities
Geron’s research program is proud to provide support for innovative investigator sponsored research (ISR) and collaborative external research. If you have a clinical, real world evidence, translational, or preclinical concept that meets one of our areas of interest and does not conflict with Geron’s current research pipeline, please complete a concept form [linked here] and send to [email protected]. Proposals may be submitted between December 9, 2025 – February 9, 2026.
Areas of Interest
- Mechanistic Understanding of the impact of imetelstat driven telomerase inhibition
- Add on or combination therapy (excluding EMAs) with imetelstat in low and INT-1 risk MDS
- Safety and activity of imetelstat in the first line setting for INT-2/high risk MDS
- Safety and activity of imetelstat as part of a condition regimen for allogenic HSCT in myeloid neoplasms
Grants, Donations and Sponsorships
Geron may provide funding for educational programs and charitable projects that further medical and scientific knowledge that align with our mission to transform the lives of patients with myeloid hematologic malignancies. Requests for funding must be submitted for review. For more information on our charitable giving and eligibility, including required documentation, please refer to a full overview here.
Educational Programs
We provide funding for CME (Continuing Medical Education) and IME (Independent Medical Education) initiatives aimed at improving care and support for people living with Myelodysplastic Syndromes and Myeloproliferative Neoplasms/Myelofibrosis to prioritized content areas as outlined in our Medical Education Overview.
Charitable Giving
Philanthropy is a key component of corporate social responsibility. Geron may provide financial support in response to unsolicited requests for charitable funding intended to benefit patients, caregivers, or patient support communities aligned to our prioritized disease areas and content areas. For inquiries, please submit your request here.
If you are unsure which link to select, this form can help.
Business development
With a seasoned leadership team with world-class expertise spanning research, clinical development, regulatory, manufacturing and commercial experience in hematologic malignancies, Geron is prepared to deliver on our mission to change lives by changing the course of blood cancer and other hematological conditions.
We are interested in accelerating value creation through strategic partnerships that have the potential to bring complementary programs, products, and capabilities that would synergize with our first-in-class telomerase inhibitor and further address unmet medical needs globally.
To contact our Business Development team, please send us an email.